Skip to main content
RESMED INC logo

RESMED INC — Investor Relations & Filings

Ticker · RMD LEI · 254900O2VD7IQ5OGI615 ASX Manufacturing
Open in API
Filings indexed 1,643 across all filing types
Latest filing 2010-04-08 Regulatory Filings
Country AU Australia
Listing ASX RMD

About RESMED INC

https://www.resmed.com

ResMed Inc. is a global leader in the development, manufacturing, and distribution of medical devices and cloud-based software solutions for the management of sleep-disordered breathing, chronic obstructive pulmonary disease, and other respiratory conditions. The company’s primary product portfolio includes continuous positive airway pressure (CPAP) devices, bilevel machines, and a variety of masks and accessories designed to improve patient adherence and comfort. ResMed distinguishes itself through its focus on digital health, offering integrated software platforms that enable remote patient monitoring and data-driven clinical insights for healthcare providers. Additionally, the company provides software-as-a-service (SaaS) solutions to support out-of-hospital care settings, including home health, hospice, and skilled nursing facilities, aiming to improve patient outcomes and reduce overall healthcare costs.

Recent filings

Filing Released Lang Actions
RMD Announces Conference Call to discuss3rd Qtr 2010 results 1
Regulatory Filings Classification · 80% confidence The document is an announcement of a conference call and webcast to discuss the third quarter 2010 financial results of ResMed Inc. It includes details about the timing of the call, how to participate, and replay information. There is no actual financial data or detailed report content included. The document is short (1960 characters) and serves as a notification for an upcoming earnings call rather than the call transcript itself or the earnings release. Therefore, it fits best under the category of Call Transcript (CT) only if it contained the full transcript, but since it is only an announcement, it does not qualify as CT. It is also not an Earnings Release (ER) because it does not contain financial highlights, only a notice of when results will be released and a call held. Given the options, the best fit is Regulatory Filings (RNS) as a general announcement that does not fit other categories, but since the document specifically announces a conference call, the closest specific category is Call Transcript (CT) if it were the transcript, but it is not. Hence, the best classification is Regulatory Filings (RNS) with moderate confidence.
2010-04-08 English
Change of Director`s Interest Notice 2 pages ?Kb
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in a director's relevant interests in securities, including the number of shares and stock options held before and after the change, the nature of the change (on-market sale pursuant to 10b5-1), and dates of transactions. This is a report of personal share transactions by a company director. The document length is 2965 characters, which is consistent with a detailed notice of director dealings rather than a brief announcement or a full financial report. Therefore, the document fits the definition of Director's Dealing (DIRS).
2010-03-11 English
Daily share buy-back notice - Appendix 3E 2 pages ?Kb
Transaction in Own Shares Classification · 100% confidence The document is titled 'Appendix 3E' and is a 'Daily share buy-back notice' related to on-market buy-back activity. It provides details about the number of shares bought back, total consideration paid, and compliance statements. The document is short (2177 characters) and focuses on reporting share repurchase activity rather than financial results or management commentary. It is not an announcement of a report but a specific transaction notice regarding the company's own shares. Therefore, it fits the category of 'Transaction in Own Shares' (POS).
2010-03-01 English
Daily share buy-back notice - Appendix 3E 2 pages ?Kb
Transaction in Own Shares Classification · 100% confidence The document is titled 'Appendix 3E' and is a 'Daily share buy-back notice' related to an on-market buy-back of shares by ResMed Inc. It provides details such as the number of shares bought back, total consideration paid, highest and lowest prices paid, and compliance statements. The document is short (2177 characters) and is a regulatory notice to the ASX about share buy-back activity. It does not contain comprehensive financial statements or detailed financial analysis, nor is it a report or announcement of a meeting or voting results. It fits the description of a 'Transaction in Own Shares' filing, which reports the company's buy-back of its own shares. Therefore, the correct classification is POS (Transaction in Own Shares).
2010-02-28 English
Daily share buy-back notice - Appendix 3E 2 pages ?Kb
Transaction in Own Shares Classification · 100% confidence The document is titled 'Appendix 3E' and is described as a 'Daily share buy-back notice' related to on-market buy-back activities. It provides details about the number of shares bought back, total consideration paid, and compliance statements. The document is short (2181 characters) and focuses on reporting share repurchase activity rather than financial results or management commentary. It includes specific data on shares bought back and prices paid, which aligns with a report of the company buying back its own shares. Therefore, this document fits the category of 'Transaction in Own Shares' (POS).
2010-02-25 English
Change of Director`s Interest Notice 2 pages ?Kb
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rules and the Corporations Act. It details changes in securities holdings by a director, including acquisitions, disposals, and exercises of stock options. The content focuses on personal share transactions by a company director. There is no indication of financial results, management discussion, or other report types. The document length is 3029 characters, which is consistent with a detailed insider trading report rather than a brief announcement or a full financial report. Therefore, this document fits the definition of 'Director's Dealing' (DIRS), which covers reports of personal share transactions by company directors and executives (insider trades).
2010-02-24 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.